Safety, tolerability and clinical implementation of ‘ready-to-use’ (68)gallium-DOTA0-Tyr3-octreotide ((68)Ga-DOTATOC) (SomaKIT TOC) for injection in patients diagnosed with gastroenteropancreatic neuroendocrine tumours (GEP-NETs)

BACKGROUND: (68)Ga-DOTA0-Tyr3-octreotide ((68)Ga-DOTATOC) positron emission tomography–CT (PET-CT) has superior diagnostic performance compared to the licensed tracer OctreoScan single photon emission CT–CT in patients with gastroenteropancreatic neuroendocrine tumours (GEP-NETs). A new preparation...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:ESMO Open
Main Authors: Manoharan, Prakash, Lamarca, Angela, Navalkissoor, Shaunak, Calero, Jose, Chan, Pei San, Julyan, Peter, Sierra, Maribel, Caplin, Martyn, Valle, Juan
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078687/
https://ncbi.nlm.nih.gov/pubmed/32188715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2019-000650
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares